Catalio Capital Management »

Newamsterdam Pharma Co Nv shares owned by Catalio Capital Management

Quarter-by-quarter ownership of Newamsterdam Pharma Co Nv (NAMS) shares owned by Catalio Capital Management from 13F filings

Historical chart of Catalio Capital Management investment in Newamsterdam Pharma Co Nv

Tip: Access up to 7 years of quarterly data

All positions including Newamsterdam Pharma Co Nv held by Catalio Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Newamsterdam Pharma Co Nv by Catalio Capital Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $2.7M 84k 32.01

More positions owned by Catalio Capital Management

Dianthus Therapeutics (DNTH)
Bridgebio Pharma (BBIO)
Ascendis Pharma A/s Sponsored Adr (ASND)
Bristol Myers Squibb (BMY)
Syndax Pharmaceuticals (SNDX)
Gilead Sciences (GILD)
Terns Pharmaceuticals (TERN)
Definium Therapeutics Com Shs (DFTX)
Soleno Therapeutics (SLNO)
Boston Scientific Corporation (BSX)
Ultragenyx Pharmaceutical (RARE)
Incyte Corporation (INCY)
Cytokinetics Com New (CYTK)
Natera (NTRA)
Corvus Pharmaceuticals (CRVS)

View all positions for Catalio Capital Management

Top funds holding Newamsterdam Pharma Co Nv

Frazier Life Sciences Management
Capital World Investors
RA Capital Management
Fcpm Iii Services B.v.
Bain Capital Life Sciences Investors
FMR
Wellington Management Company
Deerfield Management Company
Viking Global Investors
Duquesne Family Office
Polar Capital Holdings
Jennison Associates
Medicxi Ventures Management
Henderson Group
Westfield Capital Management Company

View all funds holding Newamsterdam Pharma Co Nv